Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.31 |
| ▸ | CASP7 | P55210 | 1/20 | 0.31 |
| ▸ | HBB | P68871 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | CACNB4 | O00305 | 1/20 | 0.31 |
| ▸ | CACNA1A | O00555 | 1/20 | 0.31 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.31 |
| ▸ | CACNG3 | O60359 | 1/20 | 0.31 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.31 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.31 |
| ▸ | CACNB3 | P54284 | 1/20 | 0.31 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.31 |
| ▸ | CACNG7 | P62955 | 1/20 | 0.31 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10401011 | 1.00 | BACE1 (0.38) | BACE1ALDH1A1TSHRCASP1BRCA1 | |
| SCHEMBL15584563 | 0.82 | BACE1 (0.32) | BACE1 | |
| SCHEMBL4802180 | 0.81 | ALDH1A1 (0.37) | ALDH1A1 | |
| SCHEMBL29704518 | 0.80 | BACE1 (0.31) | BACE1 | |
| SCHEMBL13845917 | 0.73 | BACE1 (0.47) | BACE1ALDH1A1TSHR | |
| SCHEMBL1702922 | 0.71 | CA2 (0.37) | — | |
| SCHEMBL4620453 | 0.71 | MAP3K14 (0.40) | TSHRGAA | |
| SCHEMBL12558640 | 0.69 | — | — | |
| SCHEMBL19625031 | 0.69 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL12102101 | 0.69 | PARP1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005069930-A2 | ASYMMETRIC HYDROGENATION OF ALPHA-AMINO CARBONYL COMPOUNDS | THE PENN STATE RESEARCH FOUNDATION (US) | 2005-08-04 | — | — | WO | claimed |
| US-20050159604-A1 | Asymmetric hydrogenation of alpha-amino carbonyl compounds | THE PENN STATE RESEARCH FOUNDATION | 2005-07-21 | — | — | US | claimed |
| US-12435181-B2 | Formulations capable of reacting with or removal of molecular oxygen | LI SHENSHEN (US) | 2025-10-07 | — | — | US | disclosed |
| WO-2023048351-A1 | COMPOSITION FOR ENCAPSULATING ORGANIC LIGHT-EMITTING DEVICE AND ORGANIC LIGHT-EMITTING DEVICE DISPLAY APPARATUS COMPRISING ORGANIC LAYER PREPARED THEREFROM | 삼성에스디아이 주식회사 | 2023-03-30 | — | — | WO | disclosed |
| WO-2023017966-A1 | COMPOSITION FOR ENCAPSULATING ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DIODE DISPLAY COMPRISING ORGANIC LAYER MANUFACTURED THEREFROM | 삼성에스디아이 주식회사 | 2023-02-16 | — | — | WO | disclosed |
| US-20220235174-A1 | Formulations capable of reacting with or removal of molecular oxygen | LI ZHENZHEN (CN) | 2022-07-28 | — | — | US | disclosed |
| CN-113966271-A | Agent capable of reacting with or removing oxygen molecules | 李蓁蓁 | 2022-01-21 | — | — | CN | disclosed |
| EP-3924160-A1 | FORMULATIONS CAPABLE OF REACTING WITH OR REMOVAL OF MOLECULAR OXYGEN | Finite Research Ltd (GB) | 2021-12-22 | — | — | EP | disclosed |
| WO-2020154728-A1 | FORMULATIONS CAPABLE OF REACTING WITH OR REMOVAL OF MOLECULAR OXYGEN | LI SHENSHEN (US) | 2020-07-30 | — | — | WO | disclosed |
| US-9145415-B2 | Nitrogen-containing heterocyclic compound or salt thereof | FUJIFILM CORPORATION (JP) | 2015-09-29 | — | — | US | disclosed |
| US-20150045339-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND OR SALT THEREOF | FUJIFILM CORPORATION (JP) | 2015-02-12 | — | — | US | disclosed |
| WO-1991005804-A1 | CATALYSIS OF DIELS-ALDER REACTIONS, METHODS AND CATALYSTS THEREFOR | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1991-05-02 | — | — | WO | disclosed |
| EP-0399351-A2 | Epoxy resin and water borne coatings therefrom | THE DOW CHEMICAL COMPANY (US) | 1990-11-28 | — | — | EP | disclosed |
| US-4946911-A | CONTAINING UNSATURATED IMIDE | THE DOW CHEMICAL COMPANY (US) | 1990-08-07 | — | — | US | disclosed |
| US-4847348-A | BINDERS, COATINGS | THE DOW CHEMICAL COMPANY (US) | 1989-07-11 | — | — | US | disclosed |
| US-4814340-A | 1,4-diaryl alkane derivatives having insecticidal and acaricidal activity | MITSUI TOATSU CHEMICALS, INC. (JP) | 1989-03-21 | — | — | US | disclosed |
| EP-0299421-A2 | Imide modified epoxy resins | THE DOW CHEMICAL COMPANY (US) | 1989-01-18 | — | — | EP | disclosed |
| US-4661501-A | Certain aryl-alkane-2-pyridyloxy-phenyl derivatives having insecticidal and acaricidal activity | MITSUI TOATSU CHEMICALS, INC. (JP) | 1987-04-28 | — | — | US | disclosed |
| US-4209590-A | USING AN N-HALOALKYTHIOPHTHALIMIDE AS PROMOTER | CHEVRON RESEARCH COMPANY (US) | 1980-06-24 | — | — | US | disclosed |
| US-4006140-A | AGING RESISTANCE IMPROVERS FOR VULCANIZABLE RUBBERS | THE B. F. GOODRICH COMPANY (US) | 1977-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150045339-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND OR SALT THEREOF | FLT3, NPM1, ABL1 | BACE1 4400/4885ALDH1A1 2553/4885TSHR 3784/4885 |
| US-20050159604-A1 | Asymmetric hydrogenation of alpha-amino carbonyl compounds | CBR1, CBR3, DECR1 | BACE1 4038/4885ALDH1A1 2147/4885TSHR 1709/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.